Jones Financial Companies
BSX icon

Jones Financial Companies’s Boston Scientific BSX Stock Holding History

Jones Financial Companies’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.2M Sell
1,293,187
-238,750
-16% -$13M 0.02% 371
2026
Q1 		$106M Buy
1,531,937
+1,487,392
+3,339% +$119M 0.05% 192
2025
Q4 		$4.25M Buy
44,545
+3,026
+7% +$297K ﹤0.01% 679
2025
Q3 		$4.08M Buy
41,519
+9,597
+30% +$994K ﹤0.01% 630
2025
Q2 		$3.4M Buy
31,922
+7,870
+33% +$796K ﹤0.01% 603
2025
Q1 		$2.39M Buy
24,052
+8,676
+56% +$874K ﹤0.01% 612
2024
Q4 		$1.37M Buy
15,376
+6,118
+66% +$539K ﹤0.01% 660
2024
Q3 		$773K Buy
9,258
+5,946
+180% +$469K ﹤0.01% 680
2024
Q2 		$255K Buy
3,312
+2,510
+313% +$184K ﹤0.01% 758
2024
Q1 		$54.9K Buy
802
+245
+44% +$15.8K ﹤0.01% 715
2023
Q4 		$32.2K Buy
557
+193
+53% +$10.3K ﹤0.01% 533
2023
Q3 		$19.2K Buy
364
+183
+101% +$9.6K ﹤0.01% 437
2023
Q2 		$9.79K Buy
181
+121
+202% +$6.32K ﹤0.01% 468
2023
Q1 		$3K Sell
60
-87
-59% -$4.1K ﹤0.01% 544
2022
Q4 		$7K Buy
147
+87
+145% +$3.77K ﹤0.01% 501
2022
Q3 		$2K Sell
60
-99
-62% -$3.97K ﹤0.01% 506
2022
Q2 		$6K Sell
159
-239
-60% -$9.73K ﹤0.01% 523
2022
Q1 		$18K Sell
398
-164
-29% -$7.11K ﹤0.01% 447
2021
Q4 		$24K Buy
562
+300
+115% +$12.6K ﹤0.01% 437
2021
Q3 		$11K Hold
262
– – ﹤0.01% 485
2021
Q2 		$11K Buy
262
+181
+223% +$7.62K ﹤0.01% 456
2021
Q1 		$3K Sell
81
-179
-69% -$6.78K ﹤0.01% 698
2020
Q4 		$9K Buy
+260
New +$9.37K ﹤0.01% 441
2013
Q4 		– Sell
-186
Closed -$2K – 263
2013
Q3 		$2K Hold
186
– – ﹤0.01% 645
2013
Q2 		$2K Buy
+186
New +$1.58K ﹤0.01% 721

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jones Financial Companies's BSX Position: Q2 2026 in Review

Jones Financial Companies reduced its Boston Scientific (BSX) stake by 16% in Q2 2026, selling an estimated $13M and leaving 1,293,187 shares worth $57.2M. The position accounts for 0.02% of the portfolio, ranked #371.

Jones Financial Companies first reported a position in BSX in Q2 2013 and has held it in 25 quarters since. The position peaked at $106M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Jones Financial Companies held 1,293,187 shares of Boston Scientific worth $57.2M as of Q2 2026.
  • Jones Financial Companies sold 238,750 Boston Scientific shares in Q2 2026, an estimated $13M.
  • Boston Scientific made up 0.02% of Jones Financial Companies's portfolio in Q2 2026, its #371 holding.
  • Jones Financial Companies first reported a position in Boston Scientific in Q2 2013 and has held it in 25 quarters since.
  • Jones Financial Companies's Boston Scientific position peaked at $106M in Q1 2026.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.